Beta
Other thyroid hormone preparations (liothyronine, desiccated thyroid)
medication Under reviewLiothyronine is a synthetic form of triiodothyronine (T3), the biologically active thyroid hormone that regulates metabolic rate, thermogenesis, cardiovascular function, and aspects of brain development and function. It acts by binding thyroid hormone receptors in cell nuclei, altering gene transcription and protein synthesis to increase energy expenditure, oxygen consumption, and turnover of carbohydrates, lipids, and proteins. Desiccated thyroid extract is a dried animal (typically porcine) thyroid gland preparation that contains both thyroxine (T4) and triiodothyronine (T3) along with other iodinated compounds in fixed ratios. In clinical practice, liothyronine and desiccated thyroid are used primarily as prescription thyroid hormone replacement or adjunctive therapy for hypothyroidism and related thyroid conditions, not as general wellness supplements in healthy individuals. When given to people with normal thyroid function, exogenous T3 can acutely increase metabolic rate, heart rate, and sympathetic nervous system activity and can induce a biochemical and clinical state resembling mild hyperthyroidism if dosed above physiologic replacement levels. Because of this narrow therapeutic window and the potential for serious adverse cardiovascular and skeletal effects, these preparations are generally reserved for specific medical indications under physician supervision. Desiccated thyroid and liothyronine are sometimes promoted off‑label in wellness settings for energy, weight loss, or cognitive enhancement, but medical guidelines consistently advise against their use for weight reduction or performance purposes in euthyroid (normal thyroid) individuals. In healthy people, excess thyroid hormone does not confer durable health benefits and instead carries clear risk of dose‑dependent adverse effects.
Research summary
Human research on liothyronine and desiccated thyroid focuses almost entirely on patients with thyroid disease (typically hypothyroidism) or, for liothyronine, on its use as an augmentation strategy in major depression. Trials directly studying benefits in healthy euthyroid adults are extremely limited and generally short term, often designed to probe pharmacokinetics or biochemical changes rather than performance or wellness outcomes. The available evidence indicates that exogenous T3 predictably alters thyroid hormone metabolites and increases metabolic activity, but does not demonstrate sustained benefits for cognition, mood, weight control, or physical performance in otherwise healthy individuals. Safety data come from a combination of randomized controlled trials in patients, large observational cohorts, and pharmacovigilance databases. These indicate that when used at appropriate replacement doses in hypothyroid patients, liothyronine is broadly comparable in safety to levothyroxine, although its shorter half‑life and higher peak levels require careful dosing. At supraphysiologic doses, or when used for weight loss, liothyronine can provoke symptoms of hyperthyroidism, including palpitations, anxiety, insomnia, and, in severe cases, arrhythmias and other serious cardiovascular events. Because essentially all outcome‑focused studies involve patients with underlying conditions rather than healthy volunteers, there is no evidence base supporting routine use of liothyronine or desiccated thyroid to enhance health in euthyroid individuals, and guidelines generally discourage such practice.
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Research
No studies found yet. Request research to discover relevant studies.
Community updates
No updates yet for this supplement.
Be the first to share your experience!